help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lytras, A.
Right arrow Articles by Cattini, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lytras, A.
Right arrow Articles by Cattini, P. A.

Molecular Endocrinology, Vol 8, 478-489, Copyright © 1994 by Endocrine Society


ARTICLES

Human chorionic somatomammotropin gene enhancer activity is dependent on the blockade of a repressor mechanism

A Lytras and PA Cattini
Department of Physiology, University of Manitoba, Winnipeg, Canada.

The human chorionic somatomammotropin genes (hCS-A and -B) are expressed at high levels in the syncytiotrophoblast during pregnancy. A 22-base-pair (bp) transcriptional enhancer factor-1 (TEF-1) element in a 1022-bp fragment of the hCS-B 3'-flanking DNA (nucleotides 1-1022) was shown to be important for efficient promoter activity in placental cells. However, the TEF-1 site used alone does not contain all of the information required for the complete enhancer activity seen with the 1022-bp fragment. A 241-bp region of the 1022-bp fragment (nucleotides 1-241) maintains full enhancer activity in placental cells. Interactions between placental nuclear factors and sequences distinct from the TEF-1 element (nucleotides 117-139) were identified by gel mobility shift assay using the up-stream region corresponding to nucleotides 1-80. Interaction between these factors and the TEF-1 element was indicated by competition of the 1-80 bp region for complex formation by a TEF-1 site. We mutated sequences within the 1-80 bp region of the 241-bp enhancer fragment and assessed the enhancer function of wild-type and modified 241-bp fragments. We identified a sequence (DF-1 site) upstream of the TEF-1 site which is required for hCS-B enhancer function. DF-1 derepresses a repressor mechanism present in the 241-bp fragment that inhibits TEF-1 activity. A component of this repressor mechanism (RF-1 site) is present in the 1-80 bp region adjacent to the DF-1 site. Gel mobility shift competition analysis shows that the RF-1 and DF-1 sites participate in the formation of a common complex or compete for common protein factors in a tissue- specific manner.


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
L. D. Norquay, X. Yang, Y. Jin, K. A. Detillieux, and P. A. Cattini
Hepatocyte Nuclear Factor-3{alpha} Binding at P Sequences of the Human Growth Hormone Locus Is Associated with Pituitary Repressor Function
Mol. Endocrinol., March 1, 2006; 20(3): 598 - 607.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Y. Jin, L. D. Norquay, X. Yang, S. Gregoire, and P. A. Cattini
Binding of AP-2 and ETS-Domain Family Members Is Associated with Enhancer Activity in the Hypersensitive Site III Region of the Human Growth Hormone/Chorionic Somatomammotropin Locus
Mol. Endocrinol., March 1, 2004; 18(3): 574 - 587.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. W. Limesand, K. M. Jeckel, and R. V. Anthony
Pur{alpha}, a Single-Stranded Deoxyribonucleic Acid Binding Protein, Augments Placental Lactogen Gene Transcription
Mol. Endocrinol., February 1, 2004; 18(2): 447 - 457.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y. Jin, F. Sheikh, K. A. Detillieux, and P. A. Cattini
Role for Early Growth Response-1 Protein in alpha 1-Adrenergic Stimulation of Fibroblast Growth Factor-2 Promoter Activity in Cardiac Myocytes
Mol. Pharmacol., May 1, 2000; 57(5): 984 - 990.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
Y. Jin, R. M. Surabhi, A. Fresnoza, A. Lytras, and P. A. Cattini
A Role for A/T-Rich Sequences and Pit-1/GHF-1 in a Distal Enhancer Located in the Human Growth Hormone Locus Control Region with Preferential Pituitary Activity in Culture and Transgenic Mice
Mol. Endocrinol., August 1, 1999; 13(8): 1249 - 1266.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
S.-W. Jiang, K. Wu, and N. L. Eberhardt
Human Placental TEF-5 Transactivates the Human Chorionic Somatomammotropin Gene Enhancer
Mol. Endocrinol., June 1, 1999; 13(6): 879 - 889.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
S.-W. Jiang, M. A. Trujillo, and N. L. Eberhardt
Human Chorionic Somatomammotropin Enhancer Function Is Mediated by Cooperative Binding of TEF-1 and CSEF-1 to Multiple, Low-Affinity Binding Sites
Mol. Endocrinol., August 1, 1997; 11(9): 1223 - 1232.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
S.-W. Jiang and N. L. Eberhardt
The Human Chorionic Somatomammotropin Enhancers Form a Composite Silencer in Pituitary Cells in Vitro
Mol. Endocrinol., August 1, 1997; 11(9): 1233 - 1244.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
P. Jacquemin, J. A. Martial, and I. Davidson
Human TEF-5 Is Preferentially Expressed in Placenta and Binds to Multiple Functional Elements of the Human Chorionic Somatomammotropin-B Gene Enhancer
J. Biol. Chem., May 16, 1997; 272(20): 12928 - 12937.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Jacquemin, J.-J. Hwang, J. A. Martial, P. Dolle, and I. Davidson
A Novel Family of Developmentally Regulated Mammalian Transcription Factors Containing the TEA/ATTS DNA Binding Domain
J. Biol. Chem., September 6, 1996; 271(36): 21775 - 21785.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-W. Jiang and N. L. Eberhardt
Involvement of a Protein Distinct from Transcription Enhancer Factor-1 (TEF-1) in Mediating Human Chorionic Somatomammotropin Gene Enhancer Function through the GT-IIC Enhanson in Choriocarcinoma and COS Cells
J. Biol. Chem., June 9, 1995; 270(23): 13906 - 13915.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society